Your browser doesn't support javascript.
loading
Melanoma: An immunotherapy journey from bench to bedside.
Navani, Vishal; Graves, Moira C; Mandaliya, Hiren; Hong, Martin; van der Westhuizen, Andre; Martin, Jennifer; Bowden, Nikola A.
Afiliação
  • Navani V; Tom Baker Cancer Centre, Calgary, AB, Canada. Vishal.navani@albertahealthservices.ca.
  • Graves MC; Centre for Drug Repurposing and Medicines Research, University of Newcastle and Hunter Medical Research Institute, University Dr, Callaghan, NSW, 2308, Australia.
  • Mandaliya H; Calvary Mater Hospital Newcastle, Edith St, Waratah, NSW, 2298, Australia.
  • Hong M; Calvary Mater Hospital Newcastle, Edith St, Waratah, NSW, 2298, Australia.
  • van der Westhuizen A; Centre for Drug Repurposing and Medicines Research, University of Newcastle and Hunter Medical Research Institute, University Dr, Callaghan, NSW, 2308, Australia.
  • Martin J; Calvary Mater Hospital Newcastle, Edith St, Waratah, NSW, 2298, Australia.
  • Bowden NA; Centre for Drug Repurposing and Medicines Research, University of Newcastle and Hunter Medical Research Institute, University Dr, Callaghan, NSW, 2308, Australia.
Cancer Treat Res ; 183: 49-89, 2022.
Article em En | MEDLINE | ID: mdl-35551656
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Melanoma Limite: Humans Idioma: En Revista: Cancer Treat Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Melanoma Limite: Humans Idioma: En Revista: Cancer Treat Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá